Keywords: lilly, continues, ly2140023, despite, inconclusive, ph, ii

Lilly continues LY2140023 despite "inconclusive" Ph II data

Article | 03 April 2009

Print This

US drug major Eli Lilly has reported inconclusive Phase II trial results from a study of LY2140023 monohydrate, also known ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in